CSI.CN
Chemesis International Inc
Price:  
0.19 
CAD
Volume:  
40,612
Canada | Pharmaceuticals

CSI.CN WACC - Weighted Average Cost of Capital

The WACC of Chemesis International Inc (CSI.CN) is 7.5%.

The Cost of Equity of Chemesis International Inc (CSI.CN) is 7.55%.
The Cost of Debt of Chemesis International Inc (CSI.CN) is 5.5%.

RangeSelected
Cost of equity6.0% - 9.1%7.55%
Tax rate0.1% - 0.3%0.2%
Cost of debt4.0% - 7.0%5.5%
WACC5.9% - 9.1%7.5%
WACC

CSI.CN WACC calculation

CategoryLowHigh
Long-term bond rate3.6%4.1%
Equity market risk premium5.5%6.5%
Adjusted beta0.440.7
Additional risk adjustments0.0%0.5%
Cost of equity6.0%9.1%
Tax rate0.1%0.3%
Debt/Equity ratio
0.020.02
Cost of debt4.0%7.0%
After-tax WACC5.9%9.1%
Selected WACC7.5%

CSI.CN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CSI.CN:

cost_of_equity (7.55%) = risk_free_rate (3.85%) + equity_risk_premium (6.00%) * adjusted_beta (0.44) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.